| Autor: |
Almurtada Razok, Fateen Ata, Sara Mohamed Ibrahim Ahmed, Dabia Hamad S H Al Mohanadi |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
World Journal of Diabetes. 13:272-274 |
| ISSN: |
1948-9358 |
| DOI: |
10.4239/wjd.v13.i3.272 |
| Popis: |
Euglycemic diabetic ketoacidosis (EDKA) is a well-known complication of sodium-glucose co-transporter 2 inhibitors, and many cases with variable onset following the initiation of these agents are reported before, with a median onset of approximately 2 wk. This letter discusses a 45-year-old lady who initially presented with ischemic stroke but developed EDKA 4 d after starting empagliflozin, a rare occurrence. The patient had severe metabolic acidosis that necessitated admission into the intensive care unit. Prompt discontinuation of empagliflozin and DKA management resulted in clinical recovery. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
